Correlation Between Design Therapeutics and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Cue Biopharma, you can compare the effects of market volatilities on Design Therapeutics and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Cue Biopharma.
Diversification Opportunities for Design Therapeutics and Cue Biopharma
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Design and Cue is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Cue Biopharma go up and down completely randomly.
Pair Corralation between Design Therapeutics and Cue Biopharma
Given the investment horizon of 90 days Design Therapeutics is expected to generate 0.83 times more return on investment than Cue Biopharma. However, Design Therapeutics is 1.21 times less risky than Cue Biopharma. It trades about 0.03 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.02 per unit of risk. If you would invest 755.00 in Design Therapeutics on August 31, 2024 and sell it today you would lose (158.00) from holding Design Therapeutics or give up 20.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Design Therapeutics vs. Cue Biopharma
Performance |
| Timeline |
| Design Therapeutics |
| Cue Biopharma |
Design Therapeutics and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Design Therapeutics and Cue Biopharma
The main advantage of trading using opposite Design Therapeutics and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Design Therapeutics vs. Cue Biopharma | Design Therapeutics vs. Tff Pharmaceuticals | Design Therapeutics vs. Eliem Therapeutics | Design Therapeutics vs. Inhibrx |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |